A Study of Cabazitaxel for Patients With Breast or Lung Cancer and Recurrent or Progressive Brain Metastases - Cabazitaxel for Brain Metastases (CaBaMet)

Clinical trial NCT02166658 · TERMINATED

Trial details

NCT number: NCT02166658
Sponsor: AIO-Studien-gGmbH
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Cancer Lung Cancer Recurrent Brain Metastases Progressive Brain Metastases

Start date: 2015-08-01
Primary completion: 2017-04-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.